(Q27110182)
Statements
1,009.404925 dalton
1 reference
Liposidomycin B (English)
5 October 2016
C₄₂H₆₇N₅O₂₁S
1 reference
Liposidomycin B (English)
5 October 2016
CC(C)CCCCCCCCC(CC(=O)OC1CN(C(C(=O)N(C1C(=O)O)C)C(C2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)OC4C(C(C(O4)CN)O)OS(=O)(=O)O)C)OC(=O)CC(C)CC(=O)O
1 reference
Liposidomycin B (English)
5 October 2016
CC(C)CCCCCCCCC(CC(=O)OC1CN(C(C(=O)N(C1C(=O)O)C)C([C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)O[C@H]4[C@@H]([C@@H]([C@H](O4)CN)O)OS(=O)(=O)O)C)OC(=O)CC(C)CC(=O)O
1 reference
Liposidomycin B (English)
5 October 2016
Identifiers
1 reference
Liposidomycin B (English)
5 October 2016
2 references
Liposidomycin B (English)
5 October 2016
1 reference
(5R)-5'-O-(5-Amino-5-deoxy-2-O-sulfo-beta-D-ribofuranosyl)-5'-C-[5-carboxy-6-({3-[(4-carboxy-3-methylbutanoyl)oxy]-12-methyltridecanoyl}oxy)-1,4-dimethyl-3-oxo-1,4-diazepan-2-yl]uridine (English)
5 October 2016
1 reference
Liposidomycin B (English)
5 October 2016